These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 18941626)
21. Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice. Skoda J; Nunukova A; Loja T; Zambo I; Neradil J; Mudry P; Zitterbart K; Hermanova M; Hampl A; Sterba J; Veselska R Tumour Biol; 2016 Jul; 37(7):9535-48. PubMed ID: 26790443 [TBL] [Abstract][Full Text] [Related]
22. Endosialin‑expressing bone sarcoma stem‑like cells are highly tumor‑initiating and invasive. Sun DX; Liao GJ; Liu KG; Jian H Mol Med Rep; 2015 Oct; 12(4):5665-70. PubMed ID: 26300407 [TBL] [Abstract][Full Text] [Related]
24. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. Sun Y; Kong W; Falk A; Hu J; Zhou L; Pollard S; Smith A PLoS One; 2009; 4(5):e5498. PubMed ID: 19430532 [TBL] [Abstract][Full Text] [Related]
25. Prognostic value of circulating CD133(+) cells in patients with gastric cancer. Xia P; Song CL; Liu JF; Wang D; Xu XY Cell Prolif; 2015 Jun; 48(3):311-7. PubMed ID: 25727099 [TBL] [Abstract][Full Text] [Related]
26. CD133(+) CD44(+) Cells Mediate in the Lung Metastasis of Osteosarcoma. He A; Yang X; Huang Y; Feng T; Wang Y; Sun Y; Shen Z; Yao Y J Cell Biochem; 2015 Aug; 116(8):1719-29. PubMed ID: 25736420 [TBL] [Abstract][Full Text] [Related]
27. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo. Tirino V; Desiderio V; Paino F; De Rosa A; Papaccio F; Fazioli F; Pirozzi G; Papaccio G FASEB J; 2011 Jun; 25(6):2022-30. PubMed ID: 21385990 [TBL] [Abstract][Full Text] [Related]
28. [Analysis of expression of cancer stem cell-related markers in orbital adenoid cystic carcinoma]. Lin TT; Zhu LM; He YJ; Zhang H Zhonghua Yan Ke Za Zhi; 2011 Aug; 47(8):703-8. PubMed ID: 22169609 [TBL] [Abstract][Full Text] [Related]
29. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties. Wu A; Oh S; Wiesner SM; Ericson K; Chen L; Hall WA; Champoux PE; Low WC; Ohlfest JR Stem Cells Dev; 2008 Feb; 17(1):173-84. PubMed ID: 18271701 [TBL] [Abstract][Full Text] [Related]
30. ABCG2 is required for self-renewal and chemoresistance of CD133-positive human colorectal cancer cells. Ma L; Liu T; Jin Y; Wei J; Yang Y; Zhang H Tumour Biol; 2016 Sep; 37(9):12889-12896. PubMed ID: 27449042 [TBL] [Abstract][Full Text] [Related]
31. A side population of cells from a human pancreatic carcinoma cell line harbors cancer stem cell characteristics. Wang YH; Li F; Luo B; Wang XH; Sun HC; Liu S; Cui YQ; Xu XX Neoplasma; 2009; 56(5):371-8. PubMed ID: 19580337 [TBL] [Abstract][Full Text] [Related]
32. Immunological and Clinical Impact of Cancer Stem Cells in Vulvar Cancer: Role of CD133/CD24/ABCG2-Expressing Cells. Napoletano C; Bellati F; Ruscito I; Pernice M; Zizzari IG; Caponnetto S; Tomao F; Frigerio L; Liberati M; Rughetti A; Caserta D; Panici PB; Nuti M Anticancer Res; 2016 Oct; 36(10):5109-5116. PubMed ID: 27798870 [TBL] [Abstract][Full Text] [Related]
33. In vivo investigation of CD133 as a putative marker of cancer stem cells in Hep-2 cell line. Wei XD; Zhou L; Cheng L; Tian J; Jiang JJ; Maccallum J Head Neck; 2009 Jan; 31(1):94-101. PubMed ID: 18853445 [TBL] [Abstract][Full Text] [Related]
35. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409 [TBL] [Abstract][Full Text] [Related]
36. Tumour CD133 mRNA expression and clinical outcome in surgically resected colorectal cancer patients. Artells R; Moreno I; Díaz T; Martínez F; Gel B; Navarro A; Ibeas R; Moreno J; Monzó M Eur J Cancer; 2010 Feb; 46(3):642-9. PubMed ID: 20005089 [TBL] [Abstract][Full Text] [Related]
37. Lack of prognostic significance of neuroendocrine differentiation and stem cell antigen co-expression in resected early-stage non-small cell lung cancer. Gottschling S; Jensen K; Herth FJ; Thomas M; Schnabel PA; Herpel E Anticancer Res; 2013 Mar; 33(3):981-90. PubMed ID: 23482770 [TBL] [Abstract][Full Text] [Related]
38. ABCG2 expression is correlated neither to side population nor to hematopoietic progenitor function in human umbilical cord blood. Alt R; Wilhelm F; Pelz-Ackermann O; Egger D; Niederwieser D; Cross M Exp Hematol; 2009 Feb; 37(2):294-301. PubMed ID: 19101070 [TBL] [Abstract][Full Text] [Related]
39. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity. Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785 [TBL] [Abstract][Full Text] [Related]
40. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer. Horst D; Scheel SK; Liebmann S; Neumann J; Maatz S; Kirchner T; Jung A J Pathol; 2009 Dec; 219(4):427-34. PubMed ID: 19621338 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]